A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...

A research team at the University of Würzburg has, for the first time, uncovered how E. coli bacteria sneak into the prostate ...

Study results are based on Surveillance, Epidemiology, and End Results-Medicare data for 166,581 patients receiving surgery or radiation for localized prostate cancer.

What Is Akeega, and Why Does It Matter? Akeega is a dual-action tablet combining two medicines — niraparib and abiraterone acetate — that has been approved by the FDA in combination with prednisone (a ...

In a recent interview with CURE, Dr. Kai Tsao discussed treatment advancements for patients with prostate cancer. In a recent interview with CURE, Dr. Kai Tsao broke down current treatment ...

University of Westminster provides funding as a member of The Conversation UK. A roster of high profile advocates, including sportsmen, actors, two previous prime ministers and over 100 MPs, have ...

Medicus Pharma is advancing Teverelix, a recently acquired, clinical stage asset, designed to address limitations of current hormone therapies for prostate cancer and benign prostatic hyperplasia (BPH ...

If you're experiencing symptoms that may indicate prostate cancer, here's what else could be causing them getty Several medical conditions can mimic prostate cancer, causing many of the same symptoms, ...

The state of prostate cancer in the U.S. is not exactly great. Just take a look at the “Prostate cancer statistics, 2025” report from the American Cancer Society, published at the beginning of ...

CLEVELAND, Ohio — A recent study led by Cleveland-area researchers suggests that prostate cancers classified as low risk may not be as low risk as previously thought. The study included researchers ...

DEAR DR. ROACH: I am a 68-year-old male who weighs 130 pounds and is 5 feet, 7 inches tall. I am in good shape and work out regularly. I had my prostate removed in 2023 after about six years of active ...